Products

What will AGI do for Baclofen?

This classification denotes a muscle relaxant with the molecular formula C10H12ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H789N3FKE8, chemically known as hydrocinnamic acid, beta-(aminomethyl)-p-chloro- but generally known as baclofen, which bears US NIH Compound Identifier 2284. European Medicines Agency schedules Baclofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05667MIG. The term BACLOFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules baclofen in its Anatomical Therapeutic Chemical (ATC) Classification. BACLOFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule baclofen under HS 29224995 and SITC 51465. As of Q4 2014, BACLOFEN remains the US FDA Preferred Term for this commodity. Baclofen bears US NLM identifiers UMLS ID C0004609 and NCI Concept Code C28858. SMILES: C1=CC(=CC=C1C(CC(=O)O)CN)CL.

How AGI delivers it

Four ways AGI delivers for Baclofen

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Baclofen, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Baclofen, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Baclofen connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Dissolution Ratemodel
  • Particle Size Distributionmodel
  • Residual Solventmodel
  • Tablet Assay Puritymodel
  • Tablet Hardnessmodel